G9770 HCPCS Level II code: Peripheral nerve block (pnb)

G9770 is the HCPCS code for “Peripheral nerve block (pnb)” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

G9770

Peripheral nerve block (pnb)

Short description: Perip nerve block

HCPCS · United States

Medicare details

The indicators CMS publishes with G9770 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
Type of service
Medical care
BETOS category
Undefined codes
Added
Jan 1, 2017

Where G9770 sits

  1. 1G codesProcedures and professional services
  2. 2Active code G9770Peripheral nerve block (pnb)

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code G9770 mean?

G9770 is the HCPCS code for “Peripheral nerve block (pnb)” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover G9770?

CMS lists G9770’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.

G9764Patient has been treated with a systemic medication for psoriasis vulgarisG9765Documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic…G9766Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatmentG9767Hospitalized patients with newly diagnosed cva considered for endovascular stroke treatmentG9768Patients who utilize hospice services any time during the measurement periodG9769Patient had a bone mineral density test in the past two years or received osteoporosis medication or therapy in the past 12 monthsG9771At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) achieved within the 30 minutes immediately before or 15 minutes…G9772Documentation of medical reason(s) for not achieving at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) within the…G9773At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) not achieved within the 30 minutes immediately before or 15…G9774Patients who have had a hysterectomyG9775Patient received at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperativelyG9776Documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g.…